Wealthspire Advisors (Maryland)
RDY icon

Wealthspire Advisors (Maryland)’s Dr. Reddy's Laboratories RDY Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-370
Closed -$3K – 1651
2019
Q1 		$3K Hold
370
– – ﹤0.01% 2041
2018
Q4 		$3K Hold
370
– – ﹤0.01% 1973
2018
Q3 		$3K Buy
370
+275
+289% +$1.84K ﹤0.01% 2057
2018
Q2 		$1K Buy
95
+60
+171% +$378 ﹤0.01% 2351
2018
Q1 		$0 Buy
+35
New +$245 ﹤0.01% 2614
2017
Q3 		– Sell
-30
Closed – – 2417
2017
Q2 		$0 Buy
30
+5
+20% +$41 ﹤0.01% 2260
2017
Q1 		$0 Buy
+25
New +$216 ﹤0.01% 1999

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Parametric Portfolio Associates
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s RDY Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Dr. Reddy's Laboratories (RDY) in Q2 2019, closing a stake of 370 shares — an estimated $3K sold.

Wealthspire Advisors (Maryland) first reported a position in RDY in Q1 2017 and held it in 7 quarters. The position peaked at $3K in Q1 2019. 150 funds tracked by Wall St. Rank hold RDY as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Dr. Reddy's Laboratories position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 370 Dr. Reddy's Laboratories shares in Q2 2019, an estimated $3K.
  • Wealthspire Advisors (Maryland) first reported a position in Dr. Reddy's Laboratories in Q1 2017 and held it in 7 quarters.
  • Wealthspire Advisors (Maryland)'s Dr. Reddy's Laboratories position peaked at $3K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.